Yang CFJ, Kumar A, Deng JZ, et al. - In treating clinical stage II (cN1) non-small-cell lung cancer (NSCLC), researchers compared the results following open vs thoracoscopic (VATS) lobectomy. They used the National Cancer Data Base (2010–2012) to assess results of cases with clinical T1-2, N1, M0 NSCLC who were managed with lobectomy without induction therapy. They followed-up of 1,559 lobectomies (1,204 open and 355 VATS) over a median of 43.2 months. Findings of this national analysis revealed that, although a minority of N1 NSCLC cases were treated with VATS lobectomy, this procedure was related to shorter hospitalization and similar nodal upstaging rates, 30-day death, and long-term survival vs open lobectomy. The feasibility of thoracoscopic techniques for the treatment of stage II (cN1) NSCLC is shown by these observations.